Drugs / Taflotan-S
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04164459 Comparator | Dec 2018 → Dec 2019 | glaucoma | Taejoon Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Taflotan-S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04164459 ↗ |
| Route | Topical | “One drop one times a day in study eye” NCT04164459 ↗ |